Jump to content

Talk:Hypertriglyceridemia

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Omega 3

[edit]

I also found this paper interesting Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance — Preceding unsigned comment added by [[User:{{{1}}}|{{{1}}}]] ([[User talk:{{{1}}}|talk]] • [[Special:Contributions/{{{1}}}|contribs]])

True, but contradicted by some other sources. JFW | T@lk 12:49, 16 September 2012 (UTC)[reply]

Exercise

[edit]

It would be good, if reliable citations are available, to say in the article whatever is known about whether exercise is helpful in treating this condition. If nothing for sure is known either way,I say it would be of value to say that, at least.--Richard L. Peterson71.198.176.141 (talk) 06:12, 14 September 2009 (UTC)[reply]

I might be able to add something on the basis of the new guideline, but in the absence of data from there we should limit ourselves to WP:MEDRS-compatible secondary sources. JFW | T@lk 12:49, 16 September 2012 (UTC)[reply]

Review

[edit]

In addition to the new Endocrine Society guideline, perhaps this review might be useful: doi:10.1503/cmaj.060963 JFW | T@lk 15:19, 12 September 2012 (UTC)[reply]

Another one about pancreatitis, but I can't retrieve the article: doi:10.1097/MOL.0b013e3283319a1d. JFW | T@lk 23:00, 13 September 2012 (UTC)[reply]

Atherosclerosis

[edit]

I have removed the following, because it is likely to be conflicting with the CPG paper, or at least will need recalibration:


Wondering how to approach this. JFW | T@lk 12:49, 16 September 2012 (UTC)[reply]

References

  1. ^ Le NA, Walter MF. The role of hypertriglyceridemia in atherosclerosis. Curr Atheroscler Rep 2007; 9:110-5.
  2. ^ Stalenhoef AF, de Graaf J. Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL. Curr Opin Lipidol 2008; 19:355-61.
  3. ^ Sniderman A, Couture P, de Graaf J. Diagnosis and treatment of apolipoprotein B dyslipoproteinemias. Nat Rev Endocrinol 2010; 6:335-46.

European Atherosclerosis Society Consensus Panel

[edit]

doi:10.1016/S2213-8587(13)70191-8 in Lancet Diab Endocrinol. JFW | T@lk 10:53, 27 December 2013 (UTC)[reply]

Endocrine Rev

[edit]

doi:10.1210/er.2014-1062 Genomic approach. JFW | T@lk 23:40, 31 January 2015 (UTC)[reply]